Skip to content

Clinical Efficacy and Safety of Deep Brain Stimulation in the Treatment of Huntington disease: a randomized controlled trial

Clinical Efficacy and Safety of Deep Brain Stimulation in the Treatment of Huntington disease: a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023831
Enrollment
Unknown
Registered
2019-06-13
Start date
2019-07-01
Completion date
Unknown
Last updated
2019-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Huntington disease

Interventions

HD-sham-DBS group:sham-DBS
HD-DBS group:DBS

Sponsors

Beijing Tiantan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged = 30 years; 2. 39 or more CAG repeats of HTT gene; 3. Meet HD diagnostic criteria based on genetic testing; 4. The major complaint is chorea; 5. Mini–Mental State Examination (MMSE) score > 25; 6. Unified Huntington's Disease Rating Scale (UHDRS) =20; 7. Before recruitment, stable medication having been used for at least 3 months, and no plan to change medication within 12 months after randomization; 8. Agree to be enrolled in this trial.

Exclusion criteria

Exclusion criteria: 1. Chorea caused by other diseases; 2. Concurrent or previously had other neurological disorders (such as stroke, optic neuromyelitis, Parkinson's disease, epilepsy, intracranial tumors, etc.); 3. Severe psychiatric disease, such as schizophrenia, bipolar disorder, major depression and paralysis, etc.; 4. Unstable condition or severe heart, lung, liver, kidney, and hematopoietic diseases; 5. Have a history of cancer unless it has been cured or does not require treatment for the next 5 years; 6. Contraindications of MRI scan.

Design outcomes

Secondary

MeasureTime frame
Mental Behavior Rating Scale;EQ-5D;MRI data;LFP;

Primary

MeasureTime frame
UHDRS;

Countries

China

Contacts

Public ContactZhang Jianguo

Beijing Tiantan Hospital, Capital Medical University

zjguo73@126.com+86 13601294613

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026